Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBM.
Management of recurrent glioblastoma multiforme (GBM) remains a challenge. Several institutions reported that a single fraction of ≥ 20 Gy for small tumor burden results in excellent local control; however, this is at the expense of a high incidence of radiation necrosis (RN). Therefore, we developed a hypofractionation pattern of 33 Gy/3 fractions, which is a radiobiological equivalent of 20 Gy, with the aim to lower the incidence of RN. We reviewed records of 21 patients with recurrent GBM treated with hypofractionated stereotactic radiation therapy (HFSRT) to their 22 respective lesions. Sixty Gy fractioned external beam radiotherapy was performed as first-line treatment. Median time from primary irradiation to HFSRT was 9.6 months (range: 3.1 - 68.1 months). In HFSRT, a median dose of 33 Gy in 11 Gy fractions was delivered to the 80% isodose line that encompassed the target volume. The median tumor volume was 1.07 cm3 (range: 0.11 - 16.64 cm3). The median follow-up time after HFSRT was 9.3 months (range: 1.7 - 33.6 months). Twenty-one of 23 lesions treated (91.3%) achieved local control while 2/23 (8.7%) progressed. Median time to progression outside of the treated site was 5.2 months (range: 2.2 - 9.6 months). Progression was treated with salvage chemotherapy. Five of 21 patients (23.8%) were alive at the end of this follow-up; two patients remain disease-free. The remaining 16/21 patients (76.2%) died of disease. Treatment was well tolerated by all patients with no acute CTC/RTOG > Grade 2. There was 0% incidence of RN. A prospective trial will be underway to validate these promising results.
Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.
Angela
A
Jia
Neurological Surgery, NewYork-Presbyterian/Weill Cornell Medical Center.
Susan C
SC
Pannullo
Radiology, NewYork-Presbyterian/Weill Cornell Medical Center.
Shlomo
S
Minkowitz
Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.
Shoshana
S
Taube
Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.
Jenghwa
J
Chang
Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.
Bhupesh
B
Parashar
Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, NewYork-Presbyterian/Weill Cornell Medical Center.
Paul
P
Christos
Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.
A Gabriella
AG
Wernicke
gliomastoma multiforme; hypofractionated; small recurrent tumor; stereotactic radiotherapy